SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2013 / Cilt: 23 - Sayı: 4

Aripiprozole bağlı diplopi: Bir olgu sunumu

Aripiprozole-induced diplopia: A case report

Yavuz SELVİ
Abdullah ATLI
Yıldız AYDIN
Mehmet Cemal KAYA
Pages
353–356
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinicians should keep in mind thatdiplopia may occur with aripiprazole treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diplopia is a condition that involves seeing doubleand impairs quality of life.
📊
Key Findings & Data:Aripiprazole is a new atypical antipsychoticagent; it has partial agonist activity at D2 and 5-HT1Areceptors and antagonist activity at 5-HT2A receptors.This paper reports development of diplopia, a rareadverse effect of psychotropic drugs, in a 24 year oldpatient with schizophreniform disorder following useof oral aripiprazole.
💡
Conclusion & Impact:Clinicians should keep in mind thatdiplopia may occur with aripiprazole treatment.
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diplopia is a condition that involves seeing doubleand impairs quality of life. Acute diplopia can be seenwith some general medical drugs and psychotropicdrugs. Aripiprazole is a new atypical antipsychoticagent; it has partial agonist activity at D2 and 5-HT1Areceptors and antagonist activity at 5-HT2A receptors.This paper reports development of diplopia, a rareadverse effect of psychotropic drugs, in a 24 year oldpatient with schizophreniform disorder following useof oral aripiprazole. Clinicians should keep in mind thatdiplopia may occur with aripiprazole treatment.

Özet

Diplopi çift görme olarak tanımlanan ve yaşam kalitesinibozan bir durumdur. Akut diplopi bazı genel tıbbiilaçlar ve psikotrop ilaç kullanımında görülmektedir.Aripiprazol D2 ve 5-HT1A reseptörlerine parsiyel agonistve 5-HT2A reseptörlerine antagonist aktivite gösterenatipik antipsikotik ajandır. Bu yazıda şizofreniformbozukluk tanısıyla takip edilen 24 yaşındaki birhastada, oral aripiprazol kullanımını takiben ortayaçıkan, diplopi olgusu bildirilmektedir. Klinisyenleraripiprazol tedavisiyle diplopi ortaya çıkabileceğiniakılda tutmalıdırlar.

🔖

Cite This Article

SELVİ, Y., ATLI, A., AYDIN, Y., KAYA, M. C. (2022). Aripiprozole bağlı diplopi: Bir olgu sunumu. Klinik Psikofarmakoloji Bülteni, Cilt: 23 - Sayı: 4, 353–356. https://ajindex.com/articles/574418

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Burde RM, Savino PJ, Trobe JD. Diplopia: Myasthenia gravis. Clinical decisions in neuro-ophthalmology. St Louis: The CV Company; 1985. p.175-8
  2. Travis MJ, Burns T, Dursun S, Fahy T, Frangou S, Gray R, et al. Aripiprazole in schizophrenia: consensus guidelines. Int J Clin Pract 2005;59(4):485-95
  3. Keck PE Jr, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003;160(9):1651-8
  4. Cleare A. Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder. Evid Based Ment Health 2008;11(4):111
  5. Storch EA, Lehmkuhl H, Geffken GR, Touchton A, Murphy TK. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety 2008;25(2):172-4
  6. Naber D, Lambert M. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2004;28(8):1213-9
  7. Gupta S, Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 2004;16(3):155-66
  8. Tsai P-C, Hsiao S-H, Chiu C-C. A case of aripiprazole- associated paroxysmal supraventricular tachycardia. J Clin Psychopharmacol 2009;29(5):506-7
  9. Rota E, Bergesio G, Dettoni E, Demicheli CM. Pisa syndrome during aripiprazole treatment: a case report. Prog. Neuropsychopharmacol. Biol Psychiatry 2007;31(1):286-7
  10. Sharma A, Sorrell JH. Aripiprazole-induced parkinsonism. Int Clin Psychopharmacol 2006;21(2):127-9
  11. Nair AG, Nair AG, George RJ, Biswas J, Gandhi RA. Aripiprazole induced transient myopia: a case report and review of literature. Cutan Ocul Toxicol 2012;31(1):74–6
  12. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo- controlled trials. Schizophr Res 2003;61(2-3):123-36
  13. Ray P, Zia Ul Haq M, Nizamie SH. Aripiprazole-induced hiccups: a case report. Gen Hosp Psychiatry 2009;31(4):382- 4
  14. Friedman JH. Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient. J Clin Psychiatry 2010;71(5):652- 3
  15. Rhee D, Pyfer M. The Wills Eye Manual. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1999. p.2-3
  16. Söylev MF, Green RL, Feldon SE. Choroidal effusion as a mechanism for transient myopia induced b